Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The TANTALUS® II for the Treatment of Type 2 Diabetes (Crossover)

This study has been completed.
Information provided by (Responsible Party):
MetaCure (USA), Inc. Identifier:
First received: February 23, 2011
Last updated: September 21, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2015
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)